Stimuli-Responsive Carbon Nanotubes for On-Demand Cancer Therapy: A Review

Area of Science:

• Nanotechnology and Materials Science
• Oncology
• Drug Delivery Systems

Background:

• Carbon nanotubes (CNTs) possess unique properties making them promising for targeted drug delivery in cancer therapy.
• Stimuli-responsive CNTs are engineered to release drugs based on internal or external triggers for on-demand treatment.
• Functionalization strategies enhance CNT solubility, biocompatibility, and responsiveness.

Purpose of the Study:

• To comprehensively review CNT-based nanocarriers for stimuli-responsive cancer therapy.
• To analyze synthesis methods, structural variations, and functionalization of CNTs.
• To discuss advances in controlled drug release, tumor penetration, and toxicity reduction.

Main Methods:

• Review of literature on stimuli-responsive CNTs for cancer therapy.
• Analysis of internal (pH, redox, enzymatic) and external (light, temperature, magnetic, ultrasound) stimuli.
• Exploration of CNT integration with polymers, peptides, and nanoparticles for multimodal applications.

Main Results:

• CNT-based systems demonstrate spatiotemporal control over drug release via pH, redox, and photothermal mechanisms.
• Multimodal therapies (chemo-photothermal, chemo-immuno, gene) are achievable by integrating CNTs with other agents.
• Significant improvements in tumor penetration and reduced systemic toxicity are observed.

Conclusions:

• Stimuli-responsive CNTs represent a significant advancement in precision oncology, enabling adaptive and patient-specific cancer treatments.
• Challenges in long-term pharmacokinetics, immunogenicity, and regulatory frameworks need addressing.
• Emerging trends like AI-driven design and personalized nanomedicine hold potential for revolutionizing cancer therapy.